news
Brand-name drug prices found to be rising at a slower pace in lower amounts
Drug companies are still raising prices for brand-name prescription medicines but not as often or by as much as they used to.
List view / Grid view
Drug Markets
news
RINVOQ™ arthritis treatment granted approval by FDA
The FDA has given its approval to RINVOQ for the treatment of active rheumatoid arthritis after the drug reached its endpoints in clinical trials.
news
US appeals court overturns patent case for Jevtana
Sanofi has won the latest appeal for the patent of its top oncology product, Jevtana (cabazitaxel).
news
Global cephalosporin drugs market projected to rise 3.34 percent
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
news
Complete response letter sent for two generic products
A complete response letter (CRL) has been sent to Dr Reddy’s for two generic products.
news
Drug supplier Aspen to pay NHS £8m after competition probe
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
news
FDA to deactivate out-of-date drug listings in its database
In order keep up-to-date records and protect public health the FDA has announced it intends to deactivate out-of-date drug listings.
news
Ebola clinical trial stopped early due to positive results
An Ebola clinical trial has been stopped early as Regeneron's REGN-EB3 therapy shows superiority to ZMapp in preventing Ebola deaths.
news
Increasing number of diseases causing alopecia boosts treatment market
The global alopecia treatment market is projected to exhibit a CAGR of 4.9 percent from 2018–2026.
news
UK pharma reputation falls due to Brexit and other factors
Less than one-third of UK patient groups rate the reputation of the pharma industry as good or excellent.
news
Liposomal medicine names to be changed to avoid errors
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion.
news
Metastatic melanoma treatment gets Breakthrough Therapy Designation
Breakthrough Therapy Designation has been granted for investigational agent bempegaldesleukin in combination with nivolumab.
news
Pharmaceutical chemical market to witness significant growth
The rise of manufacturing advanced drugs will stimulate growth in the pharmaceutical chemical market.
article
Climate change: how pharma will profit from a warming planet
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
news
Millions to be invested to prevent drug shortages for no-deal Brexit
A fund of almost £450 million has been announced by the UK Government to mitigate drug shortages in the event of a no-deal Brexit.
